Besides, clinical data from the Cancer Genome Atlas (TCGA) database showed that higher ARHGAP5-AS1 expression level was correlated to shorter overall survival (Fig. 1c) and progression-free survival (Fig. 1d) in gastric cancer patients (Table 1). This evidence concerns the gene ARHGAP5 and gastric cancer.